Viemed Healthcare, Inc. (VMD) — Financial statements
Income statement, balance sheet, and cash flow for Viemed Healthcare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 270↑20.5% | 224↑22.5% | 183↑31.8% | 139↑18.6% | 117 | |
| Cost of Revenue | 115↑26.1% | 91↑29.7% | 70↑29.7% | 54↑24.1% | 44 | |
| Gross Profit | 155↑16.7% | 133↑18.1% | 113↑33.2% | 85↑15.4% | 73 | |
| Operating Expenses | ||||||
| R&D Expenses | 3↓1.7% | 3↑10.3% | 3↑3.2% | 3↑27.8% | 2 | |
| General & Administrative Expenses | 130↑16.0% | 112↑20.0% | 94↑27.8% | 73↑22.2% | 60 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 130↑16.0% | 112↑20.0% | 94↑27.8% | 73↑22.2% | 60 | |
| Other Expenses | 1↑595.2% | -0.25↓112.8% | 2↑425.2% | 0.37↑214.2% | -0.32 | |
| Operating Expenses | 135↑16.9% | 115↑17.1% | 98↑28.8% | 76↑23.6% | 62 | |
| Total Costs & Expenses | 250↑20.9% | 206↑22.3% | 169↑29.2% | 131↑23.8% | 105 | |
| Operating Results | ||||||
| Operating Income | 21↑15.7% | 18↑24.9% | 14↑73.7% | 8↓28.7% | 12 | |
| Depreciation & Amortization | 29↑12.8% | 25↑16.0% | 22↑39.9% | 16↑38.2% | 11 | |
| EBITDA | 52↑21.9% | 42↑15.4% | 37↑47.8% | 25↑2.8% | 24 | |
| EBIT | 23↑35.4% | 17↑14.4% | 15↑61.3% | 9↓28.3% | 13 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1↓52.3% | -0.78↓83.0% | -0.42↓115.2% | -0.20↑38.1% | -0.32 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1↑52.3% | 0.78↑83.0% | 0.42↑115.2% | 0.20↓38.1% | 0.32 | |
| Non-Operating Income | -2↓334.7% | 0.95↑296.7% | -0.49↑48.1% | -0.94↑24.7% | -1 | |
| Other Income / Expenses | 1↑161.1% | -2↓2936.1% | 0.06↓91.7% | 0.74↓20.0% | 0.92 | |
| Income Before Tax | 22↑34.6% | 16↑12.4% | 14↑60.1% | 9↓28.1% | 13 | |
| Income Tax Expense | 6↑34.2% | 5↑14.8% | 4↑49.9% | 3↓18.0% | 3 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 15↑34.8% | 11↑11.4% | 10↑64.6% | 6↓31.8% | 9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 15↑32.6% | 11↑10.0% | 10↑64.6% | 6↓31.8% | 9 | |
| Bottom-Line Net Income | 15↑32.6% | 11↑10.0% | 10↑64.6% | 6↓31.8% | 9 | |
| EPS (Basic) | 0.38↑31.0% | 0.29↑7.4% | 0.27↑80.0% | 0.15↓34.8% | 0.23 | |
| EPS (Diluted) | 0.37↑32.1% | 0.28↑12.0% | 0.25↑66.7% | 0.15↓31.8% | 0.22 | |
| Weighted Average Shares | 39↑0.4% | 39↑1.0% | 38↓0.8% | 39↓2.1% | 39 | |
| Weighted Average Diluted Shares | 41↑0.0% | 41↑1.1% | 40↑1.4% | 40↓2.1% | 41 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.